What can ultrasound-guided hyaluronidase add in a filler complication?

Ultrasound may help visualize a product pocket, vascular relationship or needle tip in selected HA filler complications. It does not replace early clinical recognition and time-sensitive action, and current evidence is mainly case series and expert consensus.

This translation has no recorded clinical or medical-language review.

Direct answer

Seek a record or reasonable evidence that the product is hyaluronic acid first.
Imaging may improve targeting but does not establish one standard dose or guarantee success.
Suspected visual loss must not wait for a routine ultrasound appointment before emergency referral.

Potential contribution of imaging

High-frequency ultrasound may show selected product deposits, oedema, vessels and flow changes. Dynamic guidance can help deliver enzyme toward a defined pocket or suspicious vascular region. Image quality depends on system, probe, depth, sterile technique and facial-ultrasound training; not every material has the same appearance.

Level of evidence

A 2025 review combines three cases and nine small studies totaling 83 cases, without randomized comparison or a common dose standard. Successful cases may be more likely to appear in publication. Ultrasound guidance is therefore a promising tool, not proof of superiority in every center or permission to delay established clinical action.

Urgent versus elective use

Suspected occlusion needs urgent decisions based on pain, colour, capillary refill, vision and neurological findings. There may be more time to image elective excess product or a nodule. Allergy and injection risks still apply. Preserve product, lot, findings, images, enzyme and follow-up, and do not copy an online dose into an individual case.

Scope of this article

This content is not diagnosis, prescribing, personal risk assessment or a treatment plan. Sources may be limited to a particular product, device, task, indication or study group.

Sources and evidence limits

These links are editorial starting points used to examine the article's boundaries.

Dermal Fillers (Soft Tissue Fillers)
U.S. Food and Drug Administration (FDA) · 2023
Scope and limitations: Interpret this source only within the exact product, device, method, indication and study population it names. It does not establish personal suitability, Turkish authorization, a universal protocol or a guaranteed outcome; consult the full source and current local information.
Editorial source — not a signed clinical review
Guideline for the Management of Hyaluronic Acid Filler-Induced Vascular Occlusion
Gillian Murray, Cormac Convery, Lee Walker, Emma Davies; Complications in Medical Aesthetics Collaborative (CMAC) · 2021
Scope and limitations: Interpret this source only within the exact product, device, method, indication and study population it names. It does not establish personal suitability, Turkish authorization, a universal protocol or a guaranteed outcome; consult the full source and current local information.
Editorial source — not a signed clinical review
Safety and Potential Complications of Facial Wrinkle Correction with Dermal Fillers: A Systematic Literature Review
Audra Janovskiene, Deividas Chomicius, Dominykas Afanasjevas, Zygimantas Petronis, Dainius Razukevicius, Egle Jagelaviciene · 2024
Scope and limitations: Interpret this source only within the exact product, device, method, indication and study population it names. It does not establish personal suitability, Turkish authorization, a universal protocol or a guaranteed outcome; consult the full source and current local information.
Editorial source — not a signed clinical review
Ultrasound-Guided Hyaluronidase for Filler-Induced Arterial Ischemia: Case Series and Systematic Review
N. Azizi et al. · 2025
Scope and limitations: Interpret this source only within the exact product, device, method, indication and study population it names. It does not establish personal suitability, Turkish authorization, a universal protocol or a guaranteed outcome; consult the full source and current local information.
Editorial source — not a signed clinical review
The Use of Ultrasound Imaging in Aesthetic Injectables: A Modified Delphi Consensus
International expert Delphi panel · 2025
Scope and limitations: Interpret this source only within the exact product, device, method, indication and study population it names. It does not establish personal suitability, Turkish authorization, a universal protocol or a guaranteed outcome; consult the full source and current local information.
Editorial source — not a signed clinical review